Sio Capital Management, LLC Amgen Inc Transaction History

Sio Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $7.43 Million - $8.7 Million	-35,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $8.18 Million - $9.07 Million	35,000 New	35,000 $8.53 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $8.88 Million - $10.3 Million	-40,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $8.66 Million - $10.3 Million	40,000 New	40,000 $9.2 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $21 Million - $25.7 Million	-106,069 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $19.3 Million - $25.6 Million	106,069 New	106,069 $21.5 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $3.07 Million - $3.47 Million	-17,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $3.03 Million - $3.54 Million	17,000 New	17,000 $3.31 Million

3,173

419M

8.25M

6.39M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.